ATTENTION NASDAQ: TENX INVESTORS: Contact Berger Montague About a Tenax Therapeutics, Inc. Class Action Lawsuit
PHILADELPHIA, Oct. 30, 2026 /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) ("Tenax" or the "Company") on behalf of investors who purchased or otherwise acquired Tenax securities...
Covered in this story
Call it yourself
No calls on $TENX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tenax Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.